e-Article
426P Assessing nivolumab in class II expressing microsatellite stable (pMMR) colorectal cancer (CRC): Results of the ANICCA-Class II trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S729-S730
Subject
Language
ISSN
0923-7534